Dieter Felsenberg Selected Research

Ibandronic Acid (Boniva)

4/2015	Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients.
1/2012	Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT.
3/2010	Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study.
4/2008	Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology.
3/2008	Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
1/2008	Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.
6/2006	Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.
8/2005	Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
8/2004	Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dieter Felsenberg Research Topics

Disease

19	Osteoporosis 01/2017 - 02/2002
12	Muscular Atrophy (Muscle Atrophy) 01/2020 - 06/2005
12	Atrophy 01/2020 - 07/2007
12	Postmenopausal Osteoporosis 01/2012 - 02/2002
11	Bone Resorption 01/2018 - 02/2002
11	Osteonecrosis (Kienbock's Disease) 01/2017 - 12/2006
5	Neoplasms (Cancer) 01/2017 - 01/2007
5	Metabolic Bone Diseases (Osteopenia) 07/2013 - 02/2002
4	Pain (Aches) 08/2014 - 01/2011
4	Low Back Pain (Lumbago) 11/2011 - 07/2007
3	Hypertrophy 01/2018 - 05/2011
3	Neoplasm Metastasis (Metastasis) 04/2013 - 01/2007
3	Osteoporotic Fractures 01/2009 - 09/2003
2	Headache (Headaches) 08/2011 - 07/2004
2	Gambling (Pathological Gambling) 12/2009 - 07/2009
2	Hip Fractures (Intertrochanteric Fractures) 01/2009 - 06/2008
2	Multiple Myeloma 05/2008 - 01/2007
2	Bone Diseases (Bone Disease) 05/2008 - 01/2007
2	Breast Neoplasms (Breast Cancer) 05/2008 - 01/2007
1	Infections 11/2020
1	Back Pain (Backache) 01/2020
1	Osteoarthritis 07/2018
1	Knee Osteoarthritis 07/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Periodontal Diseases (Periodontal Disease) 01/2017
1	Hypoparathyroidism 06/2015
1	Kidney Neoplasms (Kidney Cancer) 04/2015
1	Inflammation (Inflammations) 01/2015
1	Diabetes Mellitus 01/2015
1	Thrombosis (Thrombus) 11/2013
1	Drug-Related Side Effects and Adverse Reactions 08/2011
1	Muscle Cramp (Cramp) 08/2011
1	Nausea 08/2011
1	Hypersensitivity (Allergy) 08/2011
1	Musculoskeletal Pain 08/2011
1	Venous Thromboembolism 08/2011
1	Stroke (Strokes) 08/2011
1	Atrial Fibrillation 08/2011
1	Dizziness (Lightheadedness) 08/2011
1	Tremor (Tremors) 04/2011
1	Back Injuries (Back Injury) 01/2011
1	Necrosis 06/2010
1	Primary Myelofibrosis (Myelosclerosis) 03/2010
1	Femoral Fractures (Femoral Fracture) 01/2010
1	Stomach Diseases 01/2009
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 10/2007
1	Osteitis Deformans (Paget's Disease of Bone) 01/2007
1	Hypercalciuria 09/2006
1	Hypercalcemia (Milk Alkali Syndrome) 09/2006
1	Crohn Disease (Crohn's Disease) 02/2005

Drug/Important Bio-Agent (IBA)

21	Diphosphonates (Bisphosphonates)IBA 01/2017 - 02/2002
9	Ibandronic Acid (Boniva)FDA Link 04/2015 - 08/2004
6	Biomarkers (Surrogate Marker)IBA 03/2008 - 02/2002
4	Collagen Type I (Type I Collagen)IBA 01/2018 - 07/2004
4	Denosumab FDA Link 01/2017 - 07/2008
4	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2010 - 01/2003
3	collagen type I trimeric cross-linked peptideIBA 01/2018 - 08/2005
3	Zoledronic Acid (Zometa)FDA Link 04/2015 - 02/2002
3	strontium ranelate (protelos)IBA 08/2011 - 06/2008
3	Risedronic Acid (Actonel)FDA LinkGeneric 01/2008 - 01/2003
2	Cholecalciferol (Vitamin D3)FDA Link 11/2020 - 09/2006
2	Vitamin D FDA LinkGeneric 11/2020 - 09/2006
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2014
2	Teriparatide (Parathar)FDA Link 01/2017 - 08/2011
2	CalciumIBA 06/2015 - 09/2003
2	OsteocalcinIBA 06/2010 - 07/2004
2	MineralsIBA 10/2007 - 11/2004
2	Pamidronate (Aredia)FDA LinkGeneric 06/2005 - 11/2004
1	Whey ProteinsIBA 01/2020
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 07/2018
1	ProcollagenIBA 01/2018
1	Explosive Agents (Explosives)IBA 01/2018
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2017
1	GlucocorticoidsIBA 01/2015
1	Angiogenesis InhibitorsIBA 01/2015
1	Polymethyl Methacrylate (Sol)IBA 11/2014
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2011
1	Pharmaceutical PreparationsIBA 08/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2010
1	Insulin (Novolin)FDA Link 06/2010
1	Testosterone (Sustanon)FDA Link 06/2010
1	CreatinineIBA 09/2009
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2009
1	NitrogenIBA 01/2008
1	TabletsIBA 09/2006
1	25-hydroxyvitamin DIBA 09/2006
1	Budesonide (Pulmicort)FDA LinkGeneric 02/2005

Therapy/Procedure

25	Bed Rest (Bedrest) 01/2020 - 11/2004
11	Therapeutics 01/2017 - 09/2003
3	Injections 03/2010 - 06/2006
2	Resistance Training 11/2020 - 07/2013
2	Oral Surgery (Maxillofacial Surgery) 01/2017 - 01/2015
2	Duration of Therapy 04/2015 - 10/2007
2	Intravenous Administration 03/2008 - 06/2006
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018
1	Percutaneous Coronary Intervention 01/2018
1	Contraindications 01/2017
1	Oral Hygiene (Dental Hygiene) 01/2015
1	Dentures 01/2015